A randomized double-blind controlled trial of two different doses of self-administered vaginal misoprostol for successful copper intrauterine device insertion

Objective: The current study aims to compare the efficacy and safety of 200 mcg versus 400 mcg vaginal misoprostol administered 3 h prior to intrauterine device (IUD) insertion in parous women. Study design: A randomized double-blind controlled trial. Setting: Women’s Health Hospital, Assiut, Egypt....

Full description

Bibliographic Details
Main Authors: Mohamed Khalaf, Ahmed F. Amin, Zeinab Sayed, Ihab M. El-Nashar, Ahmed M. Abbas
Format: Article
Language:English
Published: SpringerOpen 2017-12-01
Series:Middle East Fertility Society Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S111056901730016X